Skip to main content
. 2017 Aug 14;8(50):87221–87233. doi: 10.18632/oncotarget.20250

Table 1. Validation of the Cancer Hotspot Panel v2 by detecting hotspot mutations in four commonly mutated genes.

Gene mutation; amino acid (Variant Allele Frequency)
Cell line KRAS TP53 SMAD4 CDKN2A
10 ng 5 ng 1 ng 10 ng 5 ng 1 ng 10 ng 5 ng 1 ng 10 ng 5 ng 1 ng
BxPC-3 Wild Type c.659A>G; Y220C (100%) c.659A>G; Y220C (100%) c.659A>G; Y220C (100%) Homozygous deletion Homozygous deletion
PANC-1 c.35G>A; p.G12D (70.5%) c.35G>A; p.G12D (70.2%) c.35G>A; p.G12D (72.2%) c.818G>A; R273H (100%) c.818G>A; R273H (100%) c.818G>A; R273H (100%) Wild Type Homozygous deletion
MIA PaCa-2 c.34G>T; p.G12C (100%) c.34G>T; p.G12C (100%) c.34G>T; p.G12C (100%) c.742C>T; R248W (100%) c.742C>T; R248W (100%) c.742C>T; R248W (100%) Wild Type Homozygous deletion

Allele frequency shown in brackets where appropriate.